RESEARCH GRANT AWARDS
AWARDS LIST.
Totals by Year
2022 - $689,966
2021 - $749,812
2020 - $630,000
2019 - $690,000
2018 - $750,000
2017 - $747,772
2016 - $720,000
2015 - $840,000
2014 - $810,000
2013 - $808,500
2012 - $720,000
2011 - $599,780
2010 - $438,000
2009 - $435,000
2008 - $619,993
2007 - $232,600
2006 - $384,551
Leonora Slatnick, MD
2021
$30,000
Biomarker Development for Sepsis in Pediatric Oncology Patients
Paul Jedlicka, MD, PhD
2021
$30,000
Understanding the metastasis-promoting cistrome in Ewing Sarcoma
Siddhartha Mitra, PhD
2021
$30,000
Development of Chimeric Antigen Receptor Expressing macrophages and microglia to target pediatric glioblastoma
Santos Franco, PhD, Siddhartha Mitra, PhD and Adam Green, MD
2021
$60,000
Development of In utero driven Mouse Models of Diffused Midline Gliomas to study the tumor immune interactions in Pediatric Midline Gliomas
Carol Sartorius, PhD
2021
$30,000
Lipodependence of endocrine resistant breast cancer as a therapeutic target
Takeshi Yamauchi, PhD
2021
$30,000
Non-UV risk factors of melanoma
John Tentler, PhD
2021
$30,000
Cancer Research Summer Fellowship Program
Jennifer Matsuda, PhD and James Scott-Browne, PhD
2021
$60,000
Genetic manipulation of human T cell transcriptional programs to improve cancer immunotherapy
Andrew Getahun, PhD and John Cambier, PhD
2021
$60,000
Identification of novel inhibitory checkpoint receptors
Nathan Dahl, MD
2021
$30,000
Unlocking the combination: Potentiation of radiation-induced antitumor effect using clinically-relevant BH3 mimetics to effectively target DIPG
Rajeev Vibhakar, MD, PhD, MPH
2021
$30,000
Role of BMI1 in SMARB1 deleted ATRTs
Alisa Lee-Sherick, MD and C. Wyatt Shields, PhD
2021
$60,000
Assessment of Cell Types for Delivering MerTK Inhibitors to Sarcomas
Sujatha Venkataraman, PhD
2021
$30,000
Novel CAR T cell therapies to target metastatic Ewing Sarcoma
Adam Green, MD and Natalie Serkova, PhD and Mark Borden, PhD
2021
$60,000
MRI-Guided Focused Ultrasound to Improve Treatment of DIPG
Carlo Marchetti, PhD and Mayumi Fujita, MD, PhD
2021
$60,000
Identifying the role of NLRP3 in immunotherapy resistant melanomas
Matthew J. Sikora, PhD
2021
$30,000
Targeting an unexplored DNA repair deficiency and radiosensitivity in lobular breast cancer
Satyanarayan Rao, PhD
2021
$30,000
Using transcription factors to map tumor state and microenvironment
Masanori Hayashi, MD
2021
$30,000
Preclinical Investigation of BCOR rearranged solid tumors
Elizabeth Kessler, MD
2021
$29,812
Validation of a patient-reported tool to screen for geriatric impairments predictive of potential frailty in cancer patients
Swati G. Patel, MD, MS
2020
$ 30,000
Identification of Hereditary Cancer Syndromes through Advanced Polyps
Raphael Nemenoff, PhD & Erin Schenk, MD, PhD
2020
$ 60,000
The Tumor Microenvironment as a Critical Regulator of Targeted Therapy in ALK Positive Lung Cancer
Rebecca Schweppe, PhD
2020
$ 30,000
The role of Nuclear FAK in Thyroid Cancer
Ryan Marker, PhD
2020
$ 30,000
Feasibility and effectiveness of an Innovative exercise program to reduce fatigue in rural cancer survivors
Zdenek Andrysik PhD
2020
30,000
Exploring strong synergism of targeted p53 activation and translation inhibition in colorectal cancer.
Diana M. Cittelly, PhD
2020
$ 30,000
Function of Ephrin B Signaling in Breast cancer brain metastasis
Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD
2020
$ 60,000
Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells
Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD
2020
$ 60,000
The role of alpha-1 antitrypsin in cancer immunotherapy
Molishree Joshi, PhD
2020
$ 30,000
A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma
Breelyn Wilky, MD & Eduardo Davila, PhD
2020
$ 60,000
Toxicity and Biodistribution of CD*:MyD88 Engineered Autologous T Cells In Mouse Models of Melanoma and Fibrosarcoma
Zachary Graff, MD
2020
$ 30,000
Development of Bispecific CAR T-cells for the Prevention of Lineage Switch in KMT2A-rearranged Leukemia
Christine Towers, PhD
2020
$ 30,000
Identifying novel regulators of mitochondrial turn over
Paula Jedlicka, MD, PhD
2020
$ 30,000
Understanding and targeting highly metastatic EWS/FLi1-low cells in Ewing Sarcoma
Maureen Lynch, Phd & Philip Owens, PhD
2020
$ 60,000
The role of exercise in breast cancer bone metastasis
Matthew Tallaferro, PhD
2020
$ 30,000
Control of cell division through centrosomal RNA localization
Senthilnath Lakshmana Chetty, PhD
2020
$ 30,000
Combining radiation and Immunotherapy to target diffuse midline gliomas with the H3K27M mutation
Mayumi Fujita, MD, PhD & Donald Backos, PhD
2019
$ 60,000
Somatic mutations in inflammasome genes in melanoma
Jay Hesselberth, PhD
2019
$ 30,000
Single-cell methods to measure functional heterogeneity
John Tentler, PhD
2019
$ 30,000
Cancer Research Summer Fellowship Program
Isabel Schlaepfer, PhD
2019
$ 30,000
Role of fat oxidation via CPT1A in immunological response to prostate cancer
Neil Box, PhD
2019
$ 30,000
Regulation of p53 in tanning
Heather Brechbuhl, PhD
2019
$ 30,000
Defining reversible tumor traits in the obese microenvironment
Matthew Sikora, PhD
2019
$ 30,000
Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma
Paul Norman, PhD
2019
$ 30,000
Natural Killer cells can protect from developing leukemia
Adam Mueller, MD, PhD
2019
$ 30,000
Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer
Cem Altunbas, PhD
2019
$ 30,000
High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy
Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD
2019
$ 60,000
CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG
Yiqun Shellman, PhD & Martin McCarter, MD
2019
$ 60,000
Targeting anti-apoptotic pathways to improve immunotherapies for melanoma
Zachary Levi Watson, PhD
2019
$ 30,000
Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer
Shi-Long Lu, MD, PhD and Daniel Frank, PhD
2019
$ 60,000
Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy
Carol Sartorius, PhD
2019
$ 30,000
PR-RAR downregulation of protein synthesis and cell growth in breast cancer
Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD
2019
$ 60,000
Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma
Stephen Keysar, PhD
2019
$ 30,000
Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation
Rajeev Vibhakar, MD, PhD, MPH
2019
$ 30,000
Role of CDK7 in medulloblastoma
Jessica Lake, MD, MPH
2018
$ 30,000
IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas
Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD
2018
$ 60,000
Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma
Christopher Lieu, MD and Todd Pitts, MD
2018
$ 60,000
Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer
Adwitiya Kar, PhD and Margaret Wierman, MD
2018
$ 30,000
Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma
Martin McCarter, MD
2018
$ 30,000
Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function
Zhangguo Chen, PhD
2018
$ 30,000
Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy
Benjamin Bitler, PhD
2018
$ 30,000
Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance
Linda Van Dyk, PhD
2018
$ 30,000
Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis
Jennifer Hintzsche, PhD
2018
$ 30,000
Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer
Nicholas Forman, MD
2018
$ 30,000
Characterization of heterogeneous tumor subpopulations in childhood ependymoma
Jennifer DeLuca, PhD
2018
$ 30,000
Targeting Kinetochore Dysfunction in Cancer Cells
David Ryan Ormond MD
2018
$ 30,000
Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety
Courtney Jones, PhD
2018
$ 30,000
Targeting relapse leukemia stem cells through inhibition of NAD synthesis
Raul M. Torres, PhD
2018
$ 30,000
Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid
Maria Jose Contreras, PhD
2018
$ 30,000
Mechanisms of TDM1/radiation-induced toxicity in brain metastases
Mair E.A. Churchill, PhD
2018
$ 30,000
Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis
Scott Cramer, PhD and James Costello, PhD
2018
$ 60,000
Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7
John Tentler, PhD
2018
$ 30,000
Cancer Research Summer Fellowship Program
Jill Slansky PhD
2018
$ 30,000
Functional activation of low-affinity T cells in the tumor
Rebecca Schweppe, PhD
2018
$ 30,000
Cooperative Src and MAP Kinase Signaling in Thyroid Cancer
Nathan Dahl, MD
2018
$ 30,000
Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma
David Thomas, PhD and Mark Borden, PhD
2018
$ 30,000
X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy